ABOS compared with ARTV: revenue, margins and what each company keeps, and the suppliers and customers both name

ABOSAcumen Pharmaceuticals, Inc.

Mkt capRevenueRevenue

ARTVArtiva Biotherapeutics, Inc.

Mkt capRevenueRevenue

Compare

ABOSAcumen Pharmaceuticals, Inc.

ARTVArtiva Biotherapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ABOS 5

MRKMercksupplier

HALOHalozymesupplier

—JCR Pharmaceuticalsunlistedsupplier

—Lonza Salesunlistedsupplier

1 more · ABOS chain ›

Shared 0

No shared counterparties.

Only ARTV 1

—GC Cellunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ABOSAcumen Pharmaceuticals, Inc.

0.23▲+9.33%

Mkt cap$15.2MRevenue—

ARTVArtiva Biotherapeutics, Inc.

4.20▲+0.27%

Regular sessionNov 2 '26

Mkt cap$204.8MRevenue$251,000Q1 FY24

Compare

Regular sessionNov 2 '26

ABOSAcumen Pharmaceuticals, Inc.

ARTVArtiva Biotherapeutics, Inc.

0.23▲+9.33%

Price

4.20▲+0.27%

$15.2M

Mkt cap

$204.8M

—

Revenue

$251,000Q1 FY24

ABOS0.23▲+9.33%vsARTV4.20▲+0.27%Regular sessionNov 2 '26